Factors associated with persistence of arthralgia among Chikungunya virus-infected travellers: report of 42 French cases - PubMed
Factors associated with persistence of arthralgia among Chikungunya virus-infected travellers: report of 42 French cases
Sophie Larrieu et al. J Clin Virol. 2010 Jan.
Abstract
Background: In 2005-2006, a major epidemic of CHIKV infection occurred in the Islands of the south-western Indian Ocean, and longstanding manifestations seemed to be more frequent than described before.
Objectives: To describe the frequency and related factors of late clinical manifestations of CHIKV infection among imported cases living in Aquitaine area, France.
Study design: All patients recruited through the travel clinic and tropical medicine unit of the University Hospital Centre of Bordeaux with possible CHIKV infection were prospectively recorded, and confirmed cases of CHIKV infection were interviewed 2 years after infection. Factors associated with the persistence of symptoms were determined by multivariate logistic regression.
Results: Among the 29 cases followed, 17 still suffered from arthralgia 2 years after infection, and most of them had never recovered from the initial phase of the condition. The risk of persistent arthralgia tended to be higher among subjects with low educational level, subjects infected in the Reunion Island, and when initial phase lasted 30 days or more and was characterised by a severe pain.
Conclusions: Consistent with previous studies, our findings showed worsened late manifestations among patients returning from Indian Ocean area. Persistence of symptoms tended to be linked with clinical burden during the acute phase, which can be informative for early recognition and management of patients at risk for developing persistent rheumatic symptoms. Cryoglobulins failed to be identified in seronegative patients with invalidating dengue-like syndrome.
Copyright (c) 2009 Elsevier B.V. All rights reserved.
Similar articles
-
Borgherini G, Poubeau P, Jossaume A, Gouix A, Cotte L, Michault A, Arvin-Berod C, Paganin F. Borgherini G, et al. Clin Infect Dis. 2008 Aug 15;47(4):469-75. doi: 10.1086/590003. Clin Infect Dis. 2008. PMID: 18611153
-
Economopoulou A, Dominguez M, Helynck B, Sissoko D, Wichmann O, Quenel P, Germonneau P, Quatresous I. Economopoulou A, et al. Epidemiol Infect. 2009 Apr;137(4):534-41. doi: 10.1017/S0950268808001167. Epub 2008 Aug 11. Epidemiol Infect. 2009. PMID: 18694529
-
Pistone T, Ezzedine K, Schuffenecker I, Receveur MC, Malvy D. Pistone T, et al. Travel Med Infect Dis. 2009 Jan;7(1):52-4. doi: 10.1016/j.tmaid.2008.10.001. Epub 2008 Nov 18. Travel Med Infect Dis. 2009. PMID: 19174303
-
Veber M, Arrøe GR, Barfod TS. Veber M, et al. Ugeskr Laeger. 2007 Jun 11;169(24):2311-3. Ugeskr Laeger. 2007. PMID: 17594846 Review. Danish.
-
[Chikungunya fever--expanded distribution of a re-emerging tropical infectious disease].
Stock I. Stock I. Med Monatsschr Pharm. 2009 Jan;32(1):17-26. Med Monatsschr Pharm. 2009. PMID: 19205134 Review. German.
Cited by
-
de Souza TMA, Ribeiro ED, Corrêa VCE, Damasco PV, Santos CC, de Bruycker-Nogueira F, Chouin-Carneiro T, Faria NRDC, Nunes PCG, Heringer M, Lima MDRQ, Badolato-Corrêa J, Cipitelli MDC, Azeredo EL, Nogueira RMR, Dos Santos FB. de Souza TMA, et al. Viruses. 2018 Nov 12;10(11):623. doi: 10.3390/v10110623. Viruses. 2018. PMID: 30424530 Free PMC article.
-
Oviedo-Pastrana M, Méndez N, Mattar S, Arrieta G, Gomezcaceres L. Oviedo-Pastrana M, et al. Arch Public Health. 2017 Jan 6;75:1. doi: 10.1186/s13690-016-0169-1. eCollection 2017. Arch Public Health. 2017. PMID: 28074128 Free PMC article.
-
Stoermer Burrack KA, Hawman DW, Jupille HJ, Oko L, Minor M, Shives KD, Gunn BM, Long KM, Morrison TE. Stoermer Burrack KA, et al. J Virol. 2014 Apr;88(7):3719-32. doi: 10.1128/JVI.02609-13. Epub 2014 Jan 15. J Virol. 2014. PMID: 24429363 Free PMC article.
-
Enhanced attenuation of chikungunya vaccines expressing antiviral cytokines.
Chuong C, Cereghino C, Rai P, Bates TA, Oberer M, Weger-Lucarelli J. Chuong C, et al. NPJ Vaccines. 2024 Mar 12;9(1):59. doi: 10.1038/s41541-024-00843-x. NPJ Vaccines. 2024. PMID: 38472211 Free PMC article.
-
Hawman DW, Carpentier KS, Fox JM, May NA, Sanders W, Montgomery SA, Moorman NJ, Diamond MS, Morrison TE. Hawman DW, et al. J Virol. 2017 Sep 27;91(20):e00816-17. doi: 10.1128/JVI.00816-17. Print 2017 Oct 15. J Virol. 2017. PMID: 28747508 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical